mRNA regulations
mRNA Regulatory Landscape
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA32Sep 15, 2026
cell therapy
Survey of Cell Therapy Formats
Sophie Lutter, Ph.D.
Lab Thread
NI-8-26-MA48Sep 15, 2026
cell therapy
The Expanding Role of Living Cell Treatments
Sophie Lutter, Ph.D.
Lab Thread
NI-8-26-MA47Sep 15, 2026
history cell therapy
History of Cell Therapies
Sophie Lutter, Ph.D.
Lab Thread
NI-8-26-MA49Sep 15, 2026
analytics / biologic
Analytical Basics for Biologics
April Stanley, MS MBA
Nice Insight
NI-8-26-MA37Sep 15, 2026
sterile
Challenges and Innovation in Sterile Manufacturing
April Stanley, MS MBA
Nice Insight
NI-8-26-MA46Sep 15, 2026
Sterile market
Sterile CDMO Market Expansion and Capacity Trends
April Stanley, MS MBA
Nice Insight
NI-8-26-MA42Sep 15, 2026
mRNA analytics
The mRNA Therapeutics Analytical Landscape
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA10Sep 15, 2026
cell therapy
Core Analytical Frameworks in Cell Therapy Quality Control
April Stanley, MS MBA
Nice Insight
NI-8-26-MA38Aug 28, 2026
small molecules
Small Molecule Discovery and Development Trends
David Alvaro, Ph.D.
Pharma's Almanac
NI-8-26-MA50Aug 28, 2026
antibodies
Key Technologies Used in Manufacturing Antibodies
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA11Aug 28, 2026
OSD
Oral Solid Dose Manufacturing Basics
April Stanley, MS MBA
Nice Insight
NI-8-26-MA12Aug 28, 2026
Market Drivers
Small Molecule API Manufacturing Trends
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA43Aug 28, 2026
OSD
Advanced Oral Solid Dose Manufacturing Technologies
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA14Aug 28, 2026
Market Drivers
Market Drivers for Small Molecule Therapeutics
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA39Aug 27, 2026
sterile / market
Foundations of the Sterile Injectable Drugs Market
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA21Aug 27, 2026
antibody / sterile
Impact of High Concentration Antibody Products on Formulation and Manufacturing
Amelia Hepworth; April Stanley, MS MBA
Nice Insight
NI-8-26-MA23Aug 27, 2026
Small molecules
Small Molecule API Regulatory Trends
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA51Aug 27, 2026
Viral vectors
Introduction to Viral Vectors for Gene Therapy
April Stanley, MS MBA
Nice Insight
NI-8-26-MA41Aug 27, 2026
OSD
Introduction to Oral Solid Dose
David Alvaro, Ph.D.; April Stanley, MS MBA
Pharma's Almanac
NI-8-26-MA6Aug 27, 2026